IO Biotech Inc
IOBT2.125USD
-0.095-4.28%
交易中 （美东）报价延迟15分钟
140.00M总市值
亏损市盈率 TTM
关于 IO Biotech Inc 公司
IO Biotech Inc 是一家临床阶段的生物制药公司，基于 T-win 技术平台开发免疫调节癌症疗法。该公司的候选产品旨在诱导免疫系统同时靶向和破坏调节肿瘤诱导免疫抑制的多种途径。IO Biotech 的主要候选产品 IO102-IO103 旨在靶向由 IDO 和 PD-L1 等关键免疫抑制蛋白介导的免疫抑制机制。该公司开发了一系列候选产品，利用其 T-win 技术平台来解决 TME 内的目标。该公司是丹麦赫尔勒夫大学医院国家癌症免疫治疗中心的子公司。
公司简介
公司代码IOBT
公司名称IO Biotech Inc
上市日期Nov 05, 2021
CEODr. Mai-Britt Zocca, Ph.D.
员工数量80
证券类型Ordinary Share
年结日Nov 05
公司地址Ole Maaloes Veh 3
城市COPENHAGEN
上市交易所NASDAQ Global Select Consolidated
国家Denmark
邮编2200
电话4570702980
网址https://www.iobiotech.com/
公司代码IOBT
上市日期Nov 05, 2021
CEODr. Mai-Britt Zocca, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+243.31%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Mr. Brian Burkavage
Mr. Brian Burkavage
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
11.50K
+666.67%
Dr. Helen Louise Collins, M.D.
Dr. Helen Louise Collins, M.D.
Director
Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. David V. Smith
Mr. David V. Smith
Independent Director
Independent Director
--
--
Dr. Faical Miyara, Ph.D.
Dr. Faical Miyara, Ph.D.
Chief Business Officer
Chief Business Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+243.31%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Mr. Brian Burkavage
Mr. Brian Burkavage
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
11.50K
+666.67%
Dr. Helen Louise Collins, M.D.
Dr. Helen Louise Collins, M.D.
Director
Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月22日 周四
更新时间: 5月22日 周四
持股股东
股东类型
持股股东
持股股东
占比
Lundbeckfond Ventures
21.18%
Kurma Partners SA
10.35%
Vivo Capital, LLC
9.37%
HBM Partners AG
5.99%
Novo Holdings A/S
5.09%
Other
48.02%
持股股东
持股股东
占比
Lundbeckfond Ventures
21.18%
Kurma Partners SA
10.35%
Vivo Capital, LLC
9.37%
HBM Partners AG
5.99%
Novo Holdings A/S
5.09%
Other
48.02%
股东类型
持股股东
占比
Venture Capital
47.38%
Investment Advisor
8.35%
Hedge Fund
4.71%
Investment Advisor/Hedge Fund
3.44%
Research Firm
2.54%
Individual Investor
0.36%
Other
33.21%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
52
44.00M
66.79%
-12.23M
2025Q1
56
44.00M
66.79%
+640.94K
2024Q4
57
44.61M
67.71%
+1.88M
2024Q3
50
48.46M
73.56%
+5.16M
2024Q2
48
51.73M
78.53%
+7.90M
2024Q1
53
52.99M
80.43%
+6.73M
2023Q4
55
54.27M
82.38%
+8.45M
2023Q3
56
56.33M
89.04%
+20.70M
2023Q2
46
22.57M
78.34%
-5.75M
2023Q1
42
24.23M
84.91%
+7.02M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Lundbeckfond Ventures
13.95M
21.18%
--
--
Apr 11, 2025
Kurma Partners SA
6.82M
10.35%
--
--
Apr 11, 2025
Vivo Capital, LLC
6.17M
9.37%
--
--
Apr 11, 2025
HBM Partners AG
3.94M
5.99%
--
--
Apr 11, 2025
Novo Holdings A/S
3.35M
5.09%
--
--
Mar 31, 2025
PFM Health Sciences, LP
2.34M
3.55%
--
--
Mar 31, 2025
Marshall Wace LLP
2.11M
3.2%
--
--
Mar 31, 2025
BofA Global Research (US)
1.65M
2.51%
--
--
Mar 31, 2025
Pivotal Bioventure Partners Investment Advisor LLC
864.20K
1.31%
--
--
Mar 31, 2025
Morgan Stanley Smith Barney LLC
789.46K
1.2%
-69.71K
-8.11%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
